BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30299270)

  • 1. Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure.
    Arundel C; Sheriff HM; Lam PH; Mohammed SF; Jones LG; Jurgens CY; Morgan CJ; Faselis C; Allman RM; Fonarow GC; Ahmed A
    Am J Ther; 2020; 27(3):e235-e242. PubMed ID: 30299270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.
    Zullo AR; Riester MR; Erqou S; Wu WC; Rudolph JL; Steinman MA
    Drugs Aging; 2020 Oct; 37(10):755-766. PubMed ID: 32808250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.
    Zhang Y; Fonarow GC; Sanders PW; Farahmand F; Allman RM; Aban IB; Love TE; Levesque R; Kilgore ML; Ahmed A
    Am J Cardiol; 2011 Nov; 108(10):1443-8. PubMed ID: 21890091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.
    Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
    Eur J Heart Fail; 2012 Oct; 14(10):1179-88. PubMed ID: 22759445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
    Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
    Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure.
    Aronow WS; Rich MW; Goodlin SJ; Birkner T; Zhang Y; Feller MA; Aban IB; Jones LG; Bearden DM; Allman RM; Ahmed A
    J Am Med Dir Assoc; 2012 Jun; 13(5):448-52. PubMed ID: 21982687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
    Patel S; Lam PH; Kanonidis EI; Ahmed AA; Raman VK; Wu WC; Rossignol P; Arundel C; Faselis C; Kanonidis IE; Deedwania P; Allman RM; Sheikh FH; Fonarow GC; Pitt B; Ahmed A
    Am J Med; 2023 Jul; 136(7):677-686. PubMed ID: 37019372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blockers for heart failure.
    Heran BS; Musini VM; Bassett K; Taylor RS; Wright JM
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003040. PubMed ID: 22513909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
    BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.
    Yoshioka K; Matsue Y; Yamaguchi T; Kitai T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kuroda S; Matsumura A; Hirao K
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):597-605. PubMed ID: 31218508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure.
    Albert NM; Swindle JP; Buysman EK; Chang C
    J Am Heart Assoc; 2019 May; 8(9):e011089. PubMed ID: 31023122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
    Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
    Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
    Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
    Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.